Home Cart Sign in  
Chemical Structure| 93106-60-6 Chemical Structure| 93106-60-6

Structure of Enrofloxacin
CAS No.: 93106-60-6

Chemical Structure| 93106-60-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Enrofloxacin is a fluoroquinolone antibiotic used as a veterinary antibacterial agent.

Synonyms: BAY Vp 2674; PD160788; endrofloxicin.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Enrofloxacin

CAS No. :93106-60-6
Formula : C19H22FN3O3
M.W : 359.39
SMILES Code : O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCN(CC)CC4)=C3)C1=O)O
Synonyms :
BAY Vp 2674; PD160788; endrofloxicin.
MDL No. :MFCD00792463
InChI Key :SPFYMRJSYKOXGV-UHFFFAOYSA-N
Pubchem ID :71188

Safety of Enrofloxacin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Salmonella enterica subsp. enterica serovar Typhimurium 1.5 mg/l 1-4 hours To evaluate the killing effect of enrofloxacin on Salmonella in chemostats mimicking tissue environments. Results showed poor killing efficacy under nutrient-limited conditions, primarily due to restricted bacterial replication. Nature. 2025 Mar;639(8053):181-189

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Invasive salmonellosis model Intraperitoneal injection 5 mg/kg Single dose, euthanized after 1 hour To assess the anti-Salmonella activity of enrofloxacin in infected mice. Results showed poor clearance efficacy in vivo, primarily due to severe nutrient starvation restricting bacterial replication. Nature. 2025 Mar;639(8053):181-189
C57BL/6NHsd mice Gut microbiota research model Drinking water administration 85 mg/L Continuous administration for 1 week, followed by 3 weeks of recovery To evaluate the impact of enrofloxacin on gut microbiota, results showed that reduced housing density (2 mice/cage) decreased cage effects and enhanced statistical power to detect antibiotic-associated effects. Cell Rep. 2022 May 10;39(6):110783
NOD mice A22Ca2/2PI22/2NOD mice Oral administration via drinking water 0.4 mg/mL From 3 weeks of age (at weaning) continuously until 10 weeks of age To investigate the effect of enrofloxacin on gut microbiota and its role in activating and expanding insulin-reactive CD8+ T cells, results showed that enrofloxacin treatment accelerated diabetes development in male mice. Diabetes. 2019 May;68(5):1002-1013
C57BL/6J adult wild-type male mice Gulf War Illness (GWI) mouse model Oral gavage 1 mg/kg Daily for 20 weeks (5 months) To investigate the effect of prolonged antibiotic exposure on renal pathology in GWI mice, results showed that prolonged enrofloxacin and neomycin treatment exacerbated renal inflammation and fibrosis-like pathology. Cells. 2023 Dec 27;13(1):56
Mice C57BL/6J mice Oral 5 mg/kg body weight Once daily for 14 days To evaluate the effects of antibiotic therapy on behavioral and immunological responses in mice. Results showed that enrofloxacin treatment led to behavioral disturbances and impaired immune system function, particularly more pronounced in female mice. Front Immunol. 2023 May 25;14:1133358
Zebrafish Wildtype AB zebrafish and transgenic zebrafish Waterborne exposure 0.01, 0.1, 1, 10, 100 μg/L Daily renewal of exposure solutions for 10 days To evaluate the potential effects of enrofloxacin on the gut microbiota and immune function in zebrafish. Results showed that ENR significantly altered the diversity and richness of gut microbiota and induced immunosuppression, including a decrease in the number of macrophages and neutrophils. Environ Sci Technol. 2022 Jun 21;56(12):8428-8437
C57/BL6 female mice EHEC O157:H7 infection model Intraperitoneal injection 8 mg/kg Once daily for 3 days To evaluate the anti-inflammatory effects of enrofloxacin in EHEC-infected mice. Results showed that enrofloxacin treatment reduced clinical signs of inflammation, weight loss, expression of pro-inflammatory cytokines (TNF-α, IL-6, and IFN-γ), apoptosis, and markers of jejunal epithelial barrier function. Front Immunol. 2020 Jun 30;11:1361

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03575312 Healthy COMPLETED 2018-08-30 Fraunhofer Institute for Toxic... More >>ology and Experimental Medicine, Hannover, 30625, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.78mL

0.56mL

0.28mL

13.91mL

2.78mL

1.39mL

27.82mL

5.56mL

2.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories